Kuwait Endomyocardial Biopsy Market Size & Outlook

The endomyocardial biopsy market in Kuwait is expected to reach a projected revenue of US$ 0.8 million by 2030. A compound annual growth rate of 1% is expected of Kuwait endomyocardial biopsy market from 2025 to 2030.
Revenue, 2024 (US$M)
$0.8
Forecast, 2030 (US$M)
$0.8
CAGR, 2025 - 2030
1%
Report Coverage
Kuwait

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Kuwait endomyocardial biopsy market, 2018-2030 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Kuwait endomyocardial biopsy market highlights

  • The Kuwait endomyocardial biopsy market generated a revenue of USD 0.8 million in 2024 and is expected to reach USD 0.8 million by 2030.
  • The Kuwait market is expected to grow at a CAGR of 1% from 2025 to 2030.
  • In terms of segment, forceps was the largest revenue generating product in 2024.
  • Forceps is the most lucrative product segment registering the fastest growth during the forecast period.


Endomyocardial biopsy market data book summary

Market revenue in 2024USD 0.8 million
Market revenue in 2030USD 0.8 million
Growth rate1% (CAGR from 2025 to 2030)
Largest segmentForceps
Fastest growing segmentForceps
Historical data2018 - 2023
Base year2024
Forecast period2025 - 2030
Quantitative unitsRevenue in USD million
Market segmentationForceps, Accessories
Key market players worldwideArgon Medical Devices, Terumo Corp, Cardinal Health Inc, Scholten Surgical Instruments, Changzhou Lookmed Medical Instrument Co., Fehling Instruments


Other key industry trends

  • In terms of revenue, Kuwait accounted for 0.2% of the global endomyocardial biopsy market in 2024.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Middle East & Africa, South Africa endomyocardial biopsy market is projected to lead the regional market in terms of revenue in 2030.
  • Saudi Arabia is the fastest growing regional market in Middle East & Africa and is projected to reach USD 14.4 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Endomyocardial Biopsy Market Companies

Name Profile # Employees HQ Website
Fehling Instruments View profile 11-50 Karlstein, Bayern, Germany, Europe https://www.fehling-instruments.de
Changzhou Lookmed Medical Instrument Co. View profile 51-100 Changzhou, Zhejiang, China, Asia http://www.lookmedchina.com
Scholten Surgical Instruments View profile 1-10 Lodi, California, United States, North America https://www.novatome.com
Argon Medical Devices View profile 1001-5000 Plano, Texas, United States, North America http://www.argonmedical.com/
Cardinal Health Inc View profile 48000 7000 Cardinal Place, Dublin, OH, United States, 43017 https://www.cardinalhealth.com
Terumo Corp View profile 30207 2-44-1 Hatagaya, Shibuya-ku, Tokyo, Japan, 151-0072 https://www.terumo.com

Kuwait endomyocardial biopsy market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to endomyocardial biopsy market will help companies and investors design strategic landscapes.


Forceps was the largest segment with a revenue share of 75% in 2024. Horizon Databook has segmented the Kuwait endomyocardial biopsy market based on forceps, accessories covering the revenue growth of each sub-segment from 2018 to 2030.


The Kuwait endomyocardial biopsy market is in a growing phase, primarily driven by the government's healthcare initiatives. In Kuwait, where lifestyle-related diseases such as diabetes and hypertension are prevalent, there is an increasing demand for cardiac diagnostic procedures & treatment.

Healthcare providers are constantly incorporating the latest advancements in biopsy devices, ensuring that patients receive the best possible care.

Reasons to subscribe to Kuwait endomyocardial biopsy market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Kuwait endomyocardial biopsy market databook

  • Our clientele includes a mix of endomyocardial biopsy market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Kuwait endomyocardial biopsy market , including forecasts for subscribers. This country databook contains high-level insights into Kuwait endomyocardial biopsy market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Kuwait endomyocardial biopsy market size, by product, 2018-2030 (US$M)

Kuwait Endomyocardial Biopsy Market Outlook Share, 2024 & 2030 (US$M)

Kuwait endomyocardial biopsy market size, by product, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online